Status:

COMPLETED

Effects of Sailing and Cooing in the Quality of Life of Multiple Sclerosis Individuals

Lead Sponsor:

University of Thessaly

Conditions:

Multiple Sclerosis (MS) - Relapsing-remitting

Eligibility:

All Genders

Phase:

NA

Brief Summary

In this study, we aim to evaluate the impact of head and neck cooling on symptoms and psychological states in individuals with Multiple Sclerosis (MS) during a 7-day Oceans of Hope Challenge sailing t...

Detailed Description

Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by physical and cognitive impairments that significantly affect patients' quality of life. Common symptoms include fatigue,...

Eligibility Criteria

Inclusion

  • Were adults aged 18 years or older. Had a confirmed diagnosis of relapsing-remitting multiple sclerosis (RRMS) based on the 2017 McDonald criteria.
  • Had experienced no relapse within the past six months. Had an Expanded Disability Status Scale (EDSS) score between 0 and 5.5, indicating the ability to walk at least 100 meters independently without assistance.
  • Had a documented history of heat sensitivity confirmed by their physician. Had not used any cooling therapy within at least four months prior to study participation.
  • Were fluent in English (for accurate completion of questionnaires and instructions).

Exclusion

  • Used medications specifically prescribed to manage psychological MS-related symptoms (e.g., antidepressants, psychostimulants).
  • Had experienced an MS relapse within the past six months. Had an Expanded Disability Status Scale (EDSS) score greater than 5.5 (unable to walk at least 100 meters independently).
  • Had no documented history of heat sensitivity related to MS. Had used any cooling therapies within four months prior to the study participation.
  • Were unable to understand or communicate fluently in English.
  • \-

Key Trial Info

Start Date :

May 6 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 17 2023

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT06915272

Start Date

May 6 2023

End Date

May 17 2023

Last Update

April 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Greek Multiple Sclerosis Society

Thessaloniki, Greece, 55132